Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
An Open-Label, Parallel-Group, Multi-Center Phase I Study to Investigate the Pharmacokinetics of NKTR-102 for Injection (Etirinotecan Pegol) in Patients with Advanced or Metastatic Solid Tumors and Mild or Moderate Hepatic Impairment.
Open to Accrual
Defintions of terms and FAQ about clinical trials.
Anthony El-Khoueiry, M.D.
Other Trial Staff:
Anayansi Miloud, D.M., Xiomara Menendez, R.N., Jubilee Acap, R.N., Khatchik Karakozian, D.M., Molly Oswald, R.N., Sherine Elsayegh, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.